Child Allergy
6
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
The UFIM (Ultraprocessed Foods In Breast Milk) Project
Observatory of the Lille Paediatric Allergy Unit
A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
The Impact of an Evidence-based Myth-busting Information Intervention on Maternal Food Allergy Related Quality of Life, Anxiety and Self-efficacy
Impact of an Educational Tool on Quality of Life and Anxiety in Parents of Children With Nut Allergy
Development of Personalized Balanced Nutrition Concept Through an IT Platform